Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

The Protective Effect of Regular Aerobic Training on Doxorubicin-Induced Hepatotoxicity in Rats: The Insulin-Like Growth Factor System

Ailin Alishahi 1 and Sara Nasiri 2 , *
Authors Information
1 Department of Exercise Physiology, Sari Branch, Azad University, Sari, Iran
2 Department of Physical Education and Sport Sciences, Mazandaran University, Babolsar, Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: December 28, 2014, 16 (12); 61-66
  • Published Online: October 14, 2013
  • Article Type: Research Article
  • Received: June 19, 2013
  • Accepted: August 21, 2013

To Cite: Alishahi A, Nasiri S. The Protective Effect of Regular Aerobic Training on Doxorubicin-Induced Hepatotoxicity in Rats: The Insulin-Like Growth Factor System, Zahedan J Res Med Sci. 2014 ; 16(12):61-66.

Copyright © 2014 Zahedan University of Medical Sciences. All rights reserved.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Materials and Methods
  • 1. Chicco AJ, Schneider CM, Hayward R. Voluntary exercise protects against acute doxorubicin cardiotoxicity in the isolated perfused rat heart. Am J Physiol Regul Integr Comp Physiol. 2005; 289(2)-31[DOI][PubMed]
  • 2. Chicco AJ, Schneider CM, Hayward R. Exercise training attenuates acute doxorubicin-induced cardiac dysfunction. J Cardiovasc Pharmacol. 2006; 47(2): 182-9[DOI][PubMed]
  • 3. Dragojevic-Simic VM, Dobric SL, Bokonjic DR, Vucinic ZM, Sinovec SM, Jacevic VM, et al. Amifostine protection against doxorubicin cardiotoxicity in rats. Anticancer Drugs. 2004; 15(2): 169-78[PubMed]
  • 4. Kelishomi RB, Ejtemaeemehr S, Tavangar SM, Rahimian R, Mobarakeh JI, Dehpour AR. Morphine is protective against doxorubicin-induced cardiotoxicity in rat. Toxicology. 2008; 243(1-2): 96-104[DOI][PubMed]
  • 5. Wonders KY, Hydock DS, Schneider CM, Hayward R. Acute exercise protects against doxorubicin cardiotoxicity. Integr Cancer Ther. 2008; 7(3): 147-54[DOI][PubMed]
  • 6. Xu M, Sheng L, Zhu X, Zeng S, Chi D, Zhang GJ. Protective effect of tetrandrine on doxorubicin-induced cardiotoxicity in rats. Tumori. 2010; 96(3): 460-4[PubMed]
  • 7. Wang G, Zhang J, Liu L, Sharma S, Dong Q. Quercetin potentiates doxorubicin mediated antitumor effects against liver cancer through p53/Bcl-xl. PLoS One. 2012; 7(12)[DOI][PubMed]
  • 8. Ludke AR, Al-Shudiefat AA, Dhingra S, Jassal DS, Singal PK. A concise description of cardioprotective strategies in doxorubicin-induced cardiotoxicity. Can J Physiol Pharmacol. 2009; 87(10): 756-63[DOI][PubMed]
  • 9. Chicco AJ, Hydock DS, Schneider CM, Hayward R. Low-intensity exercise training during doxorubicin treatment protects against cardiotoxicity. J Appl Physiol (1985). 2006; 100(2): 519-27[DOI][PubMed]
  • 10. Ascensao A, Magalhaes J, Soares J, Ferreira R, Neuparth M, Marques F, et al. Endurance training attenuates doxorubicin-induced cardiac oxidative damage in mice. Int J Cardiol. 2005; 100(3): 451-60[DOI][PubMed]
  • 11. Dziegiel P, Surowiak P, Zabel M. Correlation of histopathological and biochemical appraisal of anthracyclin-induced myocardium damage. Folia Histochem Cytobiol. 2002; 40(2): 127-8[PubMed]
  • 12. Yen HC, Oberley TD, Vichitbandha S, Ho YS, St Clair DK. The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J Clin Invest. 1996; 98(5): 1253-60[DOI][PubMed]
  • 13. Kalyanaraman B, Joseph J, Kalivendi S, Wang S, Konorev E, Kotamraju S. Doxorubicin-induced apoptosis: implications in cardiotoxicity. Mol Cell Biochem. 2002; 234-235(1-2): 119-24[PubMed]
  • 14. Kavazis AN, Smuder AJ, Min K, Tumer N, Powers SK. Short-term exercise training protects against doxorubicin-induced cardiac mitochondrial damage independent of HSP72. Am J Physiol Heart Circ Physiol. 2010; 299(5)-24[DOI][PubMed]
  • 15. Aleem E, Elshayeb A, Elhabachi N, Mansour AR, Gowily A, Hela A. Serum IGFBP-3 is a more effective predictor than IGF-1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection. Oncol Lett. 2012; 3(3): 704-12[DOI][PubMed]
  • 16. Zumkeller W. IGFs and IGFBPs: surrogate markers for diagnosis and surveillance of tumour growth? Mol Pathol. 2001; 54(5): 285-8[PubMed]
  • 17. Cao H, Wang G, Meng L, Shen H, Feng Z, Liu Q, et al. Association between circulating levels of IGF-1 and IGFBP-3 and lung cancer risk: a meta-analysis. PLoS One. 2012; 7(11)[DOI][PubMed]
  • 18. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet. 2004; 363(9418): 1346-53[DOI][PubMed]
  • 19. Ascensao A, Oliveira PJ, Magalhaes J. Exercise as a beneficial adjunct therapy during Doxorubicin treatment--role of mitochondria in cardioprotection. Int J Cardiol. 2012; 156(1): 4-10[DOI][PubMed]
  • 20. Hydock DS, Lien CY, Schneider CM, Hayward R. Exercise preconditioning protects against doxorubicin-induced cardiac dysfunction. Med Sci Sports Exerc. 2008; 40(5): 808-17[DOI][PubMed]
  • 21. Roshan VD, Assali M, Moghaddam AH, Hosseinzadeh M, Myers J. Exercise training and antioxidants: effects on rat heart tissue exposed to lead acetate. Int J Toxicol. 2011; 30(2): 190-6[DOI][PubMed]
  • 22. Wonders KY, Hydock DS, Greufe S, Schneider CM, Hayward R. Endurance exercise training preserves cardiac function in rats receiving doxorubicin and the HER-2 inhibitor GW2974. Cancer Chemother Pharmacol. 2009; 64(6): 1105-13[DOI][PubMed]
  • 23. Ascensao A, Magalhaes J, Soares J. Endurance exercise training attenuates morphological signs of cardiac muscle damage induced by doxorubicin in male mice. Eur J Transl Myol. 2006; 16(1): 27-35
  • 24. Ibrahim SS, Barakat MA, Helmy HS. Modulating effect of carvedilol on doxorubicin-induced cardiomyopathy and hepatic damage. J Am Sci. 2010; 6(12): 20-32
  • 25. Clemmons DR. Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer. Nat Rev Drug Discov. 2007; 6(10): 821-33[DOI][PubMed]
  • 26. Jones LW, Eves ND, Courneya KS, Chiu BK, Baracos VE, Hanson J, et al. Effects of exercise training on antitumor efficacy of doxorubicin in MDA-MB-231 breast cancer xenografts. Clin Cancer Res. 2005; 11(18): 6695-8[DOI][PubMed]
  • 27. Arikawa AY, Kurzer MS, Thomas W, Schmitz KH. No effect of exercise on insulin-like growth factor-I, insulin, and glucose in young women participating in a 16-week randomized controlled trial. Cancer Epidemiol Biomarkers Prev. 2010; 19(11): 2987-90[DOI][PubMed]
  • 28. Wahl P, Zinner C, Achtzehn S, Bloch W, Mester J. Effect of high- and low-intensity exercise and metabolic acidosis on levels of GH, IGF-I, IGFBP-3 and cortisol. Growth Horm IGF Res. 2010; 20(5): 380-5[DOI][PubMed]
  • 29. Gallego R, Garcia-Albeniz X, Codony-Servat J. Correlation of matrilysin levels and IGF-1/IGFBP-3 ratio with acquired chemo-resistance in advanced colorectal cancer (ACRC). J Clin Oncol. 2008; 26(15): 424
  • 30. Żebrowska, A. , Kochańska-Dziurowicz, A. , Stanjek-Cichoracka, A. . Association between serum concentrations of anabolic hormones and their binding proteins in response to graded exercise in male athletes. World Acad Sci Eng Technol. 2012; 66(771-774)
  • 31. Sprod LK, Janelsins MC, Palesh OG, Carroll JK, Heckler CE, Peppone LJ, et al. Health-related quality of life and biomarkers in breast cancer survivors participating in tai chi chuan. J Cancer Surviv. 2012; 6(2): 146-54[DOI][PubMed]
  • 32. Friedenreich CM, Neilson HK, Woolcott CG, McTiernan A, Wang Q, Ballard-Barbash R, et al. Changes in insulin resistance indicators, IGFs, and adipokines in a year-long trial of aerobic exercise in postmenopausal women. Endocr Relat Cancer. 2011; 18(3): 357-69[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments